Morey A Blinder1, Mei Sheng Duh2, Medha Sasane3, Alex Trahey2, Carole Paley3, Francis Vekeman4. 1. Department of Medicine and Department of Pathology & Immunology, Washington University St. Louis, St. Louis, Missouri. 2. Analysis Group, Inc., Boston, Massachusetts. 3. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. 4. Analysis Group, Inc., Montréal, Quebec, Canada.
Abstract
BACKGROUND: Emergency Department Reliance (EDR: total emergency department [ED] visits/total ambulatory [outpatient + ED] visits) differentiates acute episodic ED users from those who may not have adequate access to outpatient care. OBJECTIVE: This study's aim was to investigate age-related patterns of EDR and associated health-care costs in pediatric patients with sickle cell disease (SCD) and those transitioning from pediatric to adult care. METHODS: State Medicaid data were used for this study. Patients with two or more SCD diagnoses and one or more blood transfusion were included. Quarterly rates of ED visits, EDR, SCD complications associated with ED visits, and ED visits resulting in hospitalization were evaluated. Risk factors associated with high EDR and the association between high EDR and health-care costs were explored through regression analyses. RESULTS: A total of 3208 patients were included. The most common SCD complications associated with ED visits were pain, infection, and pneumonia. Beginning at the age of 15 years, EDR rose from 0.17 to 0.29 visits per quarter at age 22 years, and remained high throughout adulthood. Regression analyses indicated that patients were most likely to have high EDR during the post-transition period and when experiencing an SCD complication. Patients with high EDR incurred statistically significantly higher inpatient and ED costs, resulting in significantly higher total health-care costs. CONCLUSIONS: Compared to children, patients transitioning to adulthood relied more on the ED for their care. In addition, patients with high EDR incurred more days in the hospital and significantly higher health-care costs, highlighting the need to improve transition-related support, including better access to primary care and increased engagement with patients with SCD.
BACKGROUND: Emergency Department Reliance (EDR: total emergency department [ED] visits/total ambulatory [outpatient + ED] visits) differentiates acute episodic ED users from those who may not have adequate access to outpatient care. OBJECTIVE: This study's aim was to investigate age-related patterns of EDR and associated health-care costs in pediatric patients with sickle cell disease (SCD) and those transitioning from pediatric to adult care. METHODS: State Medicaid data were used for this study. Patients with two or more SCD diagnoses and one or more blood transfusion were included. Quarterly rates of ED visits, EDR, SCD complications associated with ED visits, and ED visits resulting in hospitalization were evaluated. Risk factors associated with high EDR and the association between high EDR and health-care costs were explored through regression analyses. RESULTS: A total of 3208 patients were included. The most common SCD complications associated with ED visits were pain, infection, and pneumonia. Beginning at the age of 15 years, EDR rose from 0.17 to 0.29 visits per quarter at age 22 years, and remained high throughout adulthood. Regression analyses indicated that patients were most likely to have high EDR during the post-transition period and when experiencing an SCD complication. Patients with high EDR incurred statistically significantly higher inpatient and ED costs, resulting in significantly higher total health-care costs. CONCLUSIONS: Compared to children, patients transitioning to adulthood relied more on the ED for their care. In addition, patients with high EDR incurred more days in the hospital and significantly higher health-care costs, highlighting the need to improve transition-related support, including better access to primary care and increased engagement with patients with SCD.
Authors: Susan T Paulukonis; Lisa B Feuchtbaum; Thomas D Coates; Lynne D Neumayr; Marsha J Treadwell; Elliott P Vichinsky; Mary M Hulihan Journal: Pediatr Blood Cancer Date: 2016-12-21 Impact factor: 3.167
Authors: Maureen Varty; Barbara Speller-Brown; Bonnie J Wakefield; Russell D Ravert; Katherine Patterson Kelly; Lori L Popejoy Journal: Nurs Res Date: 2022 Jan-Feb 01 Impact factor: 2.381
Authors: Grace Champlin; Scott N Hwang; Andrew Heitzer; Juan Ding; Lisa Jacola; Jeremie H Estepp; Winfred Wang; Kenneth I Ataga; Curtis L Owens; Justin Newman; Allison A King; Robert Davis; Guolian Kang; Jane S Hankins Journal: Exp Biol Med (Maywood) Date: 2021-08-18
Authors: Alon Peltz; Margaret E Samuels-Kalow; Jonathan Rodean; Matthew Hall; Elizabeth R Alpern; Paul L Aronson; Jay G Berry; Kathy N Shaw; Rustin B Morse; Stephen B Freedman; Eyal Cohen; Harold K Simon; Samir S Shah; Yiannis Katsogridakis; Mark I Neuman Journal: Pediatrics Date: 2017-08-01 Impact factor: 7.124
Authors: Nancy Crego; Christian Douglas; Emily Bonnabeau; Marian Earls; Kern Eason; Elizabeth Merwin; Gary Rains; Paula Tanabe; Nirmish Shah Journal: J Am Board Fam Med Date: 2020 Jan-Feb Impact factor: 2.657
Authors: Seethal A Jacob; Emily L Mueller; Anneli R Cochrane; Aaron E Carroll; William E Bennett Journal: Pediatr Blood Cancer Date: 2019-11-14 Impact factor: 3.167
Authors: Kristen E Howell; Anjelica C Saulsberry-Abate; Joacy G Mathias; Jerlym S Porter; Jason R Hodges; Kenneth I Ataga; Sheila Anderson; Vikki Nolan; Jane S Hankins Journal: Pediatr Blood Cancer Date: 2021-07-19 Impact factor: 3.838
Authors: Donna K McClish; Wally R Smith; James L Levenson; Imoigele P Aisiku; John D Roberts; Susan D Roseff; Viktor E Bovbjerg Journal: Biomed Res Int Date: 2017-03-28 Impact factor: 3.411